Skip to main content
Photo: stanfordhealthcare.org

Stanford MS & Neuroimmunology Clinic

Palo Alto, California

Academic MS Center
14 Active TrialsInfusion CenterVirtual CareLarge Center
29 MS centers statewide · Ranked #2 in California for clinical trials

At a glance

Infusion on site
Yes
Clinical trials
14 active

What kind of place is this?

AI summary of this centre's website
Comprehensive Care TeamResearch FocusedVirtual Care AvailableInfusion On-SitePart of Major Health System

You’re in a large academic MS center where care is coordinated across neurology, rehabilitation, eye care, and other specialties. You’ll likely appreciate the on-site infusion services, video visits, support groups, and language support that can make care easier to navigate.

Facility Profile

Synthesized from this facility's public website and data sources. Not a recommendation or ranking — just a summary to help you orient.
Direct Doctor Access2/5
Support Services5/5
Clinical Trials & Research4/5
Insurance & Navigation Help4/5
Scheduling & Virtual Care5/5

About Stanford MS & Neuroimmunology Clinic

AI summary of this centre's website
This clinic combines MS and neuroimmunology care with specialized collaboration for vision issues, neuropsychology, inpatient neurology, pain, and sleep medicine. It also serves as a Neuromyelitis Optica Center and provides on-site infusion and virtual care.

Stanford MS & Neuroimmunology Clinic treats multiple sclerosis, neuromyelitis optica, MOGAD, autoimmune encephalitis, and other neuroimmune conditions. Patients have access to diagnostic testing, medication management, rehabilitation services, and on-site infusion care, along with video visits for added convenience. The clinic brings together neurologists, therapists, eye specialists, neuropsychologists, pain specialists, and sleep doctors in one coordinated setting. It is part of Stanford Health Care and Stanford Health Care Neuroscience, with support groups, a patient portal, and multilingual language support available.

Stanford MS & Neuroimmunology Clinic in Palo Alto is an academic MS center that cares for people with multiple sclerosis and other neuroimmune conditions. You can expect a multidisciplinary team, on-site infusion, virtual visits, and support for rehabilitation, vision care, and neuropsychology. It is also recognized as a Neuromyelitis Optica Center, and offers second opinions, care coordination, and financial counseling to help make treatment more manageable.

Specialized Programs

Outpatient Neurologic Rehabilitation Program
Byers Eye Institute collaboration for vision issues
Neuropsychology Clinic collaboration
neurohospitalist care
pain management support
sleep medicine support

Partnerships & Referral Network

  • Wu Tsai Neurosciences Institute (brain research partnership)

Services & Treatments

What They Treat

multiple sclerosisneuromyelitis opticaMOGADautoimmune encephalitistransverse myelitisADEMstiff person syndromeanti-GAD65 neurologic syndromesoptic neuritisneuroimmune conditionsneuro-lupus

How They Treat It

multiple sclerosis careneuroimmunology carediagnostic evaluationmedication managementrehabilitation servicesclinical trial accesssupport servicesinpatient neurology coordinationvideo visitsoral medicationinfused medicationinjectable medicationphysical therapyoccupational therapyspeech therapyplasma exchangecorticosteroidsazathioprinemycophenolaterituximabbehavioral therapypain procedurescognitive behavioral therapy

Diagnostics

MRIlumbar punctureevoked potentialsneurological examblood testsneuropsychological tests

Research & Clinical Trials

This center is currently involved in 14 clinical trials — ranked #2 in California for active trials

A Rollover Study to Evaluate the Long-Term Safety and Efficacy of Ocrelizumab In Patients With Multiple Sclerosis
Hoffmann-La Roche
Closed to new patientsPhase 3
Ocrelizumab
A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell ( CAR-T) Therapy in Subjects With Non-relapsing and Progressive Forms of Multiple Sclerosis
Stanford University
RecruitingPhase 1
KYV-101 anti-CD19 CAR-T cell therapyStandard lymphodepletion regimen
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics (PK) of a Higher Dose of Ocrelizumab in Adults With Primary Progressive Multiple Sclerosis (PPMS)
Hoffmann-La Roche
Closed to new patientsPhase 3
OcrelizumabOcrelizumabAntihistamineMethylprednisolone
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics (PK) of a Higher Dose of Ocrelizumab in Adults With Relapsing Multiple Sclerosis (RMS)
Hoffmann-La Roche
Closed to new patientsPhase 3
OcrelizumabOcrelizumabAntihistamineMethylprednisolone
A Study to Investigate the Safety, Tolerability, and Processing by the Body of Intravenous and Subcutaneous RO7121932 Administration in Participants With Multiple Sclerosis
Hoffmann-La Roche
RecruitingPhase 1
RO7121932 IVRO7121932 SC
AMT-260 Gene Therapy Study in Adults With Unilateral Refractory Mesial Temporal Lobe Epilepsy
UniQure Biopharma B.V.
RecruitingPhase 1/2
AAV9-hSyn1-miGRIK2
Autism Spectrum Disorder (ASD) and Intellectual Disability (ID) Determinants in Tuberous Sclerosis Complex (TSC)
Boston Children's Hospital
Closed to new patients
Best Available Therapy Versus Autologous Hematopoietic Stem Cell Transplant for Multiple Sclerosis (BEAT-MS)
National Institute of Allergy and Infectious Diseases (NIAID)
RecruitingPhase 3
Autologous Hematopoietic Stem Cell TransplantationBest Available Therapy (BAT)
Biobank For MS And Other Demyelinating Diseases
Accelerated Cure Project for Multiple Sclerosis
Closed to new patients
Efficacy and Safety Study of Frexalimab (SAR441344) in Adults With Nonrelapsing Secondary Progressive Multiple Sclerosis
Sanofi
RecruitingPhase 3
FrexalimabPlaceboMRI contrast-enhancing agents
KYSA-7: A Study of Anti-CD19 CAR T-Cell Therapy, in Subjects With Refractory Primary and Secondary Progressive Multiple Sclerosis
Kyverna Therapeutics
Closed to new patientsPhase 2
KYV-101Standard lymphodepletion regimenAnti-CD20 mAB
Obe-cel in Refractory Progressive Forms of Multiple Sclerosis
Autolus Limited
RecruitingPhase 1
Obecabtagene autoleucel (obe-cel)
Safety, PK and Biodistribution of 18F-OP-801 in Patients With ALS, AD, MS, PD and Healthy Volunteers
Ashvattha Therapeutics, Inc.
RecruitingPhase 1/2
18F-OP-801
Stopping TSC Onset and Progression 2B: Sirolimus TSC Epilepsy Prevention Study
Darcy Krueger
RecruitingPhase 2
SirolimusPlacebo

Insurance & Access

Contact

Stanford Neuroscience Health Center, 213 Quarry Road, Palo Alto, CA 94304

Insurance & Support

Financial Counseling
Care Coordinator
Patient Portal
Support Groups
Spanish, Chinese, Russian, Vietnamese, Arabic, American Sign Language

FAQs from Stanford MS & Neuroimmunology Clinic

The clinic treats multiple sclerosis and a range of related neuroimmune conditions, including neuromyelitis optica, MOGAD, autoimmune encephalitis, transverse myelitis, ADEM, optic neuritis, and neuro-lupus. It also cares for conditions such as stiff person syndrome and anti-GAD65 neurologic syndromes.

Yes. The clinic has on-site infusion services and treats patients with infused medications when appropriate. It also offers other medication options, including oral and injectable treatments.

Yes, video visits are available. This can be helpful for follow-up care and for visits that do not require an in-person exam or testing.

The clinic offers diagnostic evaluation with MRI, lumbar puncture, evoked potentials, neurological exams, blood tests, and neuropsychological testing. These tools help the team evaluate symptoms and guide treatment.

Yes. Patients can access rehabilitation services, support groups, financial counseling, care coordination, and collaboration with specialists such as eye doctors, neuropsychologists, pain specialists, and sleep doctors.

MS Centers Across the U.S.

Click a state to browse its MS treatment centers.

The app

Check out the MS Buddy app

Track symptoms, monitor wellness, and stay on top of your MS care. It’s free, with no ads. Built by people living with MS.

Download on the App StoreGet it on Google Play
Call Website